CGEM vs TM · $830.3M cap vs P/E 9.7, rev $234.60B
Cullinan Oncology LLC (CGEM) versus Toyota Motor Corporation ADR (TM) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
CGEM currently screens at market cap $830.3M. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Not investment advice. Open the CGEM and TM stock pages for the full models.
Not investment advice.